By analyzing whole blood containing no anticoagulants (uncoagulated whole blood) immediately after collection, we evaluated the relative changes in the concentrations of ionized calcium and other electrolytes in whole blood collected in dry hepannized syringes and in serum prepared from blood collected in evacuated blood-collection tubes. Using these dry heparinized syringes, we collected and analyzed whole blood that contained either 33 or 13 mt. units of lithium hepann or 40 mt.units of electrolytebalanced hepann per milliliter of blood. We evaluated the effects both of these hepanns at different concentrations of ionized calcium and of the incomplete filling of the syringes. We conclude that: (a) when analyzed within 2-3 mm after collection, uncoagulated whole blood provides ionized calcium resufts unaffected by anticoagulants or cellular metabolism; (b) the preparation of serum unpredictably changes ionized calcium; (c) the use of dry electrolyte-balanced hepann virtually eliminates the interference in ionized calcium concentrations between 0.9 and 1.6 mmol/L; and ( incomplete filling of electrolytebalanced hepannized syringes produces no effect in syringes two-thirds full (60 mt. units/mL heparin concentration) and a small effect in syringes one-third full (120 mt. units/mL heparin).
A frequent and persistent problem in measuring ionized calcium accurately is the interference by heparin, which is used as an anticoagulant in blood-collection devices (1) (2) (3) (4) (5) . Although serum prepared from blood collected in sealed, evacuated tubes encounters no interference from heparin, the time required for clotting and centriftigation is too long for critical-care monitoring and allows glycolytic production of acids by blood cells, which may alter the concentration of ionized calcium (6). Because of syringes can be produced, and microbial contamination of the syringes may be a problem. This solution also dilutes any other constituents not contained in the solution, e.g., potassium and albumin.
Therefore, the optimal heparinized syringe should: contain a dry anticoagulant, not alter the concentration of any constituent that will be analyzed in the blood, and be produced commercially and aseptically in sufficient quantity to be the only blood-drawing syringe used at a hospital.
A commercially produced syringe containing a dry electrolyte-balanced heparin is now available. Although this product may possess several of the desired properties noted above, an earlier study, in which both aqueous solutions and serum were added to syringes containing a calcium-heparin solution, found the following effects of 35 int. units of calcium heparin per milliliter of blood: for ionized calcium at 0.75 mmol/L, the calcium heparmn increased ionized calcium in serum by 2.3%; at 2.50 mmol/L, the ionized calcium in serum was decreased by 2.2% (7) . Therefore, we have evaluated a syringe containing a dry electrolyte-balanced heparin by studying the effect of this heparin over a range of ionized calcium concentrations and in situations when the syringes were not completely filled with blood. to 0.06 mmoLfL. We suspected that cell metabolism during serum preparation had altered the ionized calcium concentration.
Materials and Methods

Syringes
Therefore, we analyzed whole blood containing no heparin within 2 mm after collection. Because this type of sample should have minimsl or no effect on ionized calcium concentration attributable to either heparmn content or cellular metabolism, we used results from uncoagulated whole blood as controls in the comparisons.
To study the effect of cellular metabolism, we measured lactate in three types of samples, collected from each of five healthy donors, with the following results: in serum prepared from blood clotted for 20 mm at room temperature and centrifuged for 5 mm (lactate = 1.64 ± 0.30 mmol/L), in whole blood collected in balancedheparinized syringes analyzed within 5 mm (lactate = 0.88 ± 0.23 mmol/L), and in uncoagulated whole blood analyzed within 2 mm (lactate = 0.74 ± 0.18 mmol/L). These results confirm that cells produce lactate during the clotting and centrifugation, causing variable effects on the ionized calcium concentration (8).
Next we compared ionized calcium results for 22 samples from which we prepared and analyzed serum, uncoagulated whole blood, whole blood with balanced heparin at 40 mt. units/mL, and whole blood with lithium heparin at 13 or 33 mt. units/mL. With uncoagulated whole blood as the control, the average difference between serum and uncoagulated whole blood was very small (-0.008 mmol/L), whereas the variation was large: the SD of differences = 0.026 mmol/L and the range of differences = -0.06 to 0.05 mmol/L. Both the SD and range of differences were more than threefold greater than in the comparison between uncoagulated whole blood and whole blood with balanced heparin (SD of differences mmol/L from uncoagulated whole blood. Although these samples were obvious outliers, with differences of -0.06 and -0.07 mmol/L at ionized calcium concentrations of about 1.20 mmol/L, we did not exclude them from our data. Also, using syringes containing balanced heparmn, we collected 15 samples from patients undergoing major surgical operations. The ionized calcium concentrations, which ranged from 1.05 to 1.25 mmol/L, never deviated by >0.02 mmol/L from results of the uncoagulated whole blood (data not shown).
We investigated the effect of balanced heparin, 40 int. units/inL, in blood samples having a range of ionized calcium concentrations. In Figure 1 We also studied the effect on ionized calcium of incompletely filling the 3-mL syringes with blood. From each blood sample collected from 19 donors, we filled three syringes with 3,2, and 1 mL of blood. As Figure 2 shows, whereas the syringe containing lithium heparmn had the expected pronounced effect, the syringe containing balanced heparin had virtually no effect on the mean ionized calcium concentration. For syringes onethird full ( Because calcium is added to the balanced-heparin syringes, we measured total calcium in several samples collected in these syringes. We found that the added calcium is detectable as a mean (± SD) increase in total calcium of 0.06 ± 0.04 mmollL, with a range of difference of 0 to 0.11. Thus, these samples are not well suited for analysis of total calcium.
Our comparison of results for sodium, potassium, and pH confirms that neither the ordinary lithium heparin, the reduced heparin, nor the balanced heparmn affected these analyses as compared with results for uncoagulated whole blood. We also found that incomplete fIlling of the syringes had virtually no effect on these analyses. Except for one difference of 2 mmol/L, no comparisons for sodium differed by >1 mmolfL; for potassium, none differed by >0.1 mmol/L; and for pH, the maximum difference of incomplete filling was 0.02. In 22 comparisons between serum and whole blood, sodium differed by 1 mmol/L and potassium by 0.2 mmol/L. However, as indicated by the changes in ionized calcium in serum, the pH differed substantially in some serum samples compared with that in uncoagulated whole blood, with differences ranging from 0.01 to 0.10 (mean ± SD: 0.04 ± 0.02).
DIscussion
To evaluate the effects of different blood-collection products on laboratory results, one must establish which type of sample, by virtue of having the fewest interferences or biases, can be used as a control in the comparisons. Although properly collected and processed serum is sometimes believed to give the most nearly accurate ionized calcium result, our study reconfirms that serum may have metabolic artifacts from accumulation of hydrogen and lactate ions (8). Because uncoagulated whole blood has no additives and virtually no artifacts due to metabolism, we believe that this type of sample, analyzed within 3 mm after collection, represents a nearly ideal control sample to determine the effects of additives, sample-handling procedures, and storage conditions on electrolyte measurements. Perhaps the only disadvantage is that the analyzer must be close to the subject providing blood.
Another key factor in studies comparing relatively small differences among samples is the precision of the analyzer. The Radiometer ICA-1 ionized calcium analyzer used in our study consistently gives within-run precision (CV) of 0.4-0.7%. We believe that use of an ionized calcium analyzer with, e.g., a CV of 2%, would at least partly obscure the true differences between samples. Our study shows that use of the dry balancedheparin syringes causes no clinically significant bias to measurements of sodium, potassium, or pH at balancedheparin concentrations of 120 mt. units/mL in blood.
Although dry lithium heparin negatively biases measurements of ionized calcium, the use of balanced hep- Even though ordinary heparin has been known for years to lower ionized calcium results, this effect can be compensated for somewhat both by using only one type of heparinized syringe within a hospital and by adjusting reference intervals appropriately for heparmnized whole blood. However, neither of these procedures can compensate for incompletely filled heparinized syringes, which, by increasing the heparmn concentration, will proportionally lower the ionized calcium concentration even further. Our study of incompletely filled syringes shows that the use of balanced heparin minimizes this effect. In syringes two-thirds full, containing balanced heparin at 60 mt. unita/rnL, the maximal effect was 0.03 mmol/L through the entire ionized calcium concentration range of 0.65 to 2.05 mmol/L. In syringes one-third full, containing balanced heparin at 120 mt. units/mL, results for ionized calcium were seldom >0.03 mmol/L different from those for the filled syringe, differing by 0.05 to 0.06 mmol/L only at the very lowest and highest ionized calcium concentrations. Therefore, in an ionized calcium range of 0.7 to 1.8 mmol/L, the balancedheparin syringes reduce the effect of incomplete filling to 0.03 mmolJL, even at a balanced-heparin concentration of 120 mt. unitslmL.
A disadvantage of balanced heparmn over ordinary heparin is that, because of the calcium added to balance the heparin binding, one should not measure total calcium on plasma obtained from these syringes. Although this is an unlikely request in critical-care monitoring, it would be a nuisance when analysis for total calcium is requested for this type of sample.
Clearly, the dry balanced-heparin syringes represent a significant advance over ordinary lithium-heparinized samples for measurement of ionized calcium. However, the user should be aware of small to moderate biases when a syringe is about one-third full or less, because the bias may be noticeable, especially at very low or high concentrations of ionized calcium. Also, total calcium should not be measured in plasma from these syringes.
